Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028964 · ClinicalTrials.gov registry record · Phase 1
Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00028964: Completed Phase 1 study, sponsored by University of California, San Francisco.
NCT00028964 is a Phase 1 study that has completed, run by University of California, San Francisco. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00028964, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Herbs used in traditional Chinese medicine may decrease the side effects of chemotherapy. PURPOSE: Randomized phase I/II trial to study the effectiveness of herbs used in traditional Chinese medicine in decreasing the side effects of chemotherapy after surgery in women who have stage I, stage II, or early stage III breast cancer.
Interventions
- DRUG cyclophosphamide
- PROCEDURE adjuvant therapy
- DRUG doxorubicin hydrochloride
- DIETARY_SUPPLEMENT Chinese herbs
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-02 |
| Est. Completion | 2005-02 |
| Phase | Phase 1 |
What the finished NCT00028964 record still lists
NCT00028964 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 4 interventions - of which cyclophosphamide is the first listed.
NCT00028964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00028964 about?
NCT00028964 is a clinical study titled "Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer". RATIONALE: Herbs used in traditional Chinese medicine may decrease the side effects of chemotherapy. PURPOSE: Randomized phase I/II trial to study the effectiveness of herbs used in traditional Chinese medicine in decreasing the side effects of chemotherapy after surgery in women who have stage I, ...
What is the current status of trial NCT00028964?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-02. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00028964?
The interventions under investigation include: cyclophosphamide (DRUG), adjuvant therapy (PROCEDURE), doxorubicin hydrochloride (DRUG), Chinese herbs (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00028964?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia